Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Atara Biotherapeutics, Inc. Transaction History

Mitsubishi Ufj Kokusai Asset Management Co., Ltd.

$92.2 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$2.85 - $5.18 $37,181 - $67,578	13,046 Added 26.65%	61,994 $203,000
Q3 2022 Nov 01, 2022	BUY	$2.85 - $8.73 $2,639 - $8,083	926 Added 1.93%	48,948 $185,000
Q2 2022 Aug 04, 2022	BUY	$4.69 - $9.84 $144,447 - $303,062	30,799 Added 178.82%	48,022 $374,000
Q1 2022 May 09, 2022	BUY	$8.44 - $16.89 $9,216 - $18,443	1,092 Added 6.77%	17,223 $160,000
Q4 2021 Feb 07, 2022	SELL	$14.7 - $19.89 $83,157 - $112,517	-5,657 Reduced 25.96%	16,131 $272,000
Q3 2021 Nov 04, 2021	BUY	$11.99 - $17.9 $6,618 - $9,880	552 Added 2.6%	21,788 $390,000
Q2 2021 Aug 06, 2021	BUY	$12.89 - $16.58 $60,080 - $77,279	4,661 Added 28.12%	21,236 $330,000
Q1 2021 May 06, 2021	BUY	$14.0 - $20.72 $69,538 - $102,916	4,967 Added 42.79%	16,575 $238,000
Q4 2020 Feb 09, 2021	SELL	$12.67 - $26.23 $69,951 - $144,815	-5,521 Reduced 32.23%	11,608 $228,000
Q3 2020 Nov 10, 2020	SELL	$11.92 - $15.87 $333 - $444	-28 Reduced 0.16%	17,129 $222,000
Q2 2020 Aug 06, 2020	BUY	$7.53 - $14.93 $36,294 - $71,962	4,820 Added 39.07%	17,157 $250,000
Q1 2020 May 11, 2020	BUY	$5.69 - $17.78 $12,717 - $39,738	2,235 Added 22.12%	12,337 $105,000
Q4 2019 Feb 05, 2020	BUY	$10.89 - $16.79 $46,685 - $71,978	4,287 Added 73.72%	10,102 $162,000
Q3 2019 Nov 12, 2019	BUY	$12.03 - $19.94 $10,020 - $16,610	833 Added 16.72%	5,815 $82,000
Q2 2019 Aug 08, 2019	BUY	$19.05 - $41.04 $8,153 - $17,565	428 Added 9.4%	4,982 $100,000
Q1 2019 Apr 26, 2019	BUY	$28.4 - $41.74 $14,540 - $21,370	512 Added 12.67%	4,554 $181,000
Q4 2018 Feb 08, 2019	BUY	$30.9 - $42.97 $30,096 - $41,852	974 Added 31.75%	4,042 $115,000
Q3 2018 Nov 13, 2018	BUY	$35.05 - $43.5 $107,533 - $133,458	3,068 New	3,068 $127,000

Others Institutions Holding ATRA

# of Institutions

Shares Held

2.89M

Call Options Held

Put Options Held

View Full List

About Atara Biotherapeutics, Inc.

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.08B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

More about ATRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.

Account